Celularity Inc (CELU)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $20.45M
Last updated: Nov 17, 2026 at 4:15 PM ET
Celularity Inc (CELU) Stock Chart
Celularity (CELU) has a latest price of $0.56 on Nov 17, 2026, 77.9% below its 52-week high of $2.55. Its price fell 63.6% over the past 12 months. The month-end price fell 98.8% over the 5 years through Oct 2026, a compound annual decline of 58.8%.
Price Chart
From Sep 2019 to Oct 2026, its highest month-end close was $116.90 in Apr 2022 and its lowest $0.60 in Jun 2026, adjusted for splits.
Month-end closes, adjusted for splits. Dividends are not included.
Chart CELU with Advanced Charting
Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for CELU.
Free with a GNG account. No credit card.
Price Performance
Over the past 3 months the price fell 27.5%, and over 6 months it fell 30.0%. The month-end price fell 63.5% over the 3 years through Oct 2026, a compound annual decline of 28.5%.
| Period | Change |
|---|---|
| 1 month | -51.4% |
| 3 months | -27.5% |
| 6 months | -30.0% |
| 12 months | -63.6% |
| 12 months, with dividends | -63.6% |
| Period | Change | Per year |
|---|---|---|
| 3 years | -63.5% | -28.5% |
| 5 years | -98.8% | -58.8% |
Price by Year
Its best calendar year was 2020, when the price rose 10.6%, and its weakest was 2023, when it fell 80.8%.
| Year | Close | Change |
|---|---|---|
| 2026 through Oct 2026 | $0.80 | -27.9% |
| 2025 | $1.11 | -46.6% |
| 2024 | $2.08 | -15.9% |
| 2023 | $2.47 | -80.8% |
| 2022 | $12.90 | -74.8% |
| 2021 | $51.20 | -53.5% |
| 2020 | $110.00 | +10.6% |
Trading Range
The price is 50.5% below its 50-day average of $1.14 and 46.4% below its 200-day average of $1.05.
| Measure | Value | Price vs |
|---|---|---|
| Latest price (Nov 17, 2026) | $0.56 | |
| 52-week high | $2.55 | -77.9% |
| 52-week low | $0.56 | +0.8% |
| 50-day average | $1.14 | -50.5% |
| 200-day average | $1.05 | -46.4% |
Price Risk
Over 3 years, its largest fall from a peak was 91.9%.
| Measure | Value |
|---|---|
| 1-year beta | 1.94 |
| Largest fall, 1 year | -73.1% |
| Largest fall, 3 years | -91.9% |
Advanced Charting Features
Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.
- Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
- Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
- Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
- Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.
Frequently Asked Questions About CELU
What is CELU's 1-year price change?
Celularity's price fell 63.6% over the past 12 months. With dividends included, the 12-month total return was -63.6%.
What is CELU's 5-year price change?
Celularity's month-end price fell 98.8% over the 5 years through Oct 2026, a compound annual decline of 58.8%. These figures leave out dividends.
What is CELU's 52-week high and low?
Celularity's 52-week high is $2.55 and its 52-week low is $0.56. Its latest price of $0.56 on Nov 17, 2026 is 77.9% below the high.
What is CELU's beta?
Celularity's 1-year beta against the S&P 500 is 1.94, so its price has moved more than the market over the past year. Its largest fall from a peak over the past year was 73.1%.
Is the CELU chart free?
Yes. Advanced Charting for CELU is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.
CELU pages: Overview, Charting, Earnings, Financials, Statistics, Competitors